Exploring the prevalence and characteristics of human epidermal growth factor receptor 2 (HER2) alterations in non-small cell lung cancer: Analysis from a Malaysian cohort

被引：0
|
作者：
Yap, N. Y. [1 ]
Perumal, K. [1 ]
Rajadurai, P. [2 ]
机构：
[1] SJMC Sime Darby Med Ctr Subang Jaya, Lab, Subang Jaya, Malaysia
[2] Subang Jaya Med Ctr, Pathol, Subang Jaya, Malaysia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.665
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
587P
引用
收藏
页码：S1699 / S1700
页数：2
相关论文
共 50 条
  • [41] The role of aromatase and epidermal growth factor receptor in non-small cell lung cancer
    Kritikou, I.
    Giannopoulou, E.
    Koutras, A.
    Dimitropoulos, K.
    Kalofonos, H.
    EJC SUPPLEMENTS, 2010, 8 (05): : 135 - 135
  • [42] Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer
    Lourdes, Laura S.
    Jalal, Shadia I.
    Hanna, Nasser
    ONCOLOGIST, 2015, 20 (09): : 975 - 978
  • [43] Audit of Epidermal Growth Factor Receptor (EGFR) Mutation Analysis in Non-Small Cell Lung Cancer (NSCLC) in an Irish Cohort
    O'Brien, O.
    Graham, D.
    McCarthy, J.
    Burke, L.
    JOURNAL OF PATHOLOGY, 2015, 237 : S24 - S24
  • [44] Clinicopathologic and molecular characteristics in ERBB2 (HER2)-altered non-small cell lung cancer
    Lee, Y.
    Lee, B.
    Choi, Y.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S151 - S152
  • [45] Analysis of metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
    Chen, Yu
    Deng, Juan
    Liu, Yu
    Wang, Hao
    Zhao, Sha
    He, Yayi
    Zhou, Caicun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
  • [46] Light on the horizon for HER2 overexpressing non-small cell lung cancer?
    Koster, Kira-Lee
    Frueh, Martin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2025, 14 (02) : 305 - 309
  • [47] HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies
    Uy, Natalie F.
    Merkhofer, Cristina M.
    Baik, Christina S.
    CANCERS, 2022, 14 (17)
  • [48] Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osimertinib
    Liu, Shengwu
    Li, Shuai
    Hai, Josephine
    Wang, Xiaoen
    Chen, Ting
    Quinn, Max M.
    Gao, Peng
    Zhang, Yanxi
    Ji, Hongbin
    Cross, Darren A. E.
    Wong, Kwok-Kin
    CLINICAL CANCER RESEARCH, 2018, 24 (11) : 2594 - 2604
  • [49] HER2 mutations in Chinese patients with non-small cell lung cancer
    Song, Zhengbo
    Yu, Xinmin
    Shi, Zhiyong
    Zhao, Jun
    Zhang, Yiping
    ONCOTARGET, 2016, 7 (47) : 78152 - 78158
  • [50] The Prognostic Significance of HER2 Overexpression in Non-small Cell Lung Cancer
    Takenaka, Masaru
    Hanagiri, Takeshi
    Shinohara, Shinji
    Kuwata, Taiji
    Chikaishi, Yasuhiro
    Oka, Soich
    Shigematsu, Yoshiki
    Nagata, Yoshika
    Shimokawa, Hidehiko
    Nakagawa, Makoto
    Uramoto, Hidetaka
    So, Tomoko
    Tanaka, Fumihiro
    ANTICANCER RESEARCH, 2011, 31 (12) : 4631 - 4636
12345